<?xml version="1.0" encoding="UTF-8"?><Articles><Article><id>462</id><JournalTitle>IMPACT OF HORMONE REPLACEMENT THERAPY ON HYPERANDROGENICITY AND GLUCOSE HOMEOSTASIS IN POSTMENOPAUSAL DIABETIC WOMEN</JournalTitle><Abstract>Hyperandrogenicity in women is closely associated with insulin resistance and a risk factor for cardiovascular
disease and noninsulin-dependent diabetes mellitus. It is known that hormone replacement therapy (HRT) decreases
hyperandrogenicity and improves glucose homeostasis in postmenopausal diabetic women. To investigate the role of HRT on
hyperandrogenicity and glucose homeostasis in postmenopausal diabetic women. A total of 40 type 2 diabetic
postmenopausal women were prospectively enrolled and followed for 12 months. The examined group consisted of 20
women who were assigned to take HRT, while the rest were left without hormone therapy. HRT consisted of 17Î²- estradiol
(E2) 1 mg and DRSP (drospirenone) 2 mg. Fasting blood glucose ( FPG), glycosylated hemoglobin (HbA1C), insulin, sex
hormone binding globuline (SHBG) and total testosterone were measured, free androgen index (FAI) was calculated by
formula and insulin sensitivity was determined by the homeostatic model assessment of insulin resistance ( HOMA-IR). All
metabolic measurements were taken at baseline and after 12 months.HRT treatment, compared with control group, was
followed by a marked increase of SHBG (from 29.0 Â± 12.3 to 56.0 Â± 8.54 nmol/l) and significant decrease of free
testosterone (5.17 Â± 1.2 to 1.92 Â± 1.3), FPG (7.8 Â± 0.86 to 6.9 Â± 0.6 mmol/l), HbA1C(7.6 Â± 0.54 to 7.2 Â± 0.43 % and
HOMA-IR (4.23 Â± 1.7 to 3.18 Â± 1.4 ÂµU/ml-mmol/l).HRT in postmenopausal diabetic women ameliorated
hyperandrogenicity, accompanied by marked improvements in glucose homeostasis</Abstract><Email>ibitovska@yahoo.com</Email><articletype>Research</articletype><volume>6</volume><issue>2</issue><year>2016</year><keyword>Hormone replacement therapy,Menopause,Hyperandrogenicity,Diabetes mellitus,Insulin resistance</keyword><AUTHORS>I. Bitoska, B. Krstevska,T. Milenkovik,S. J.Mishevska, S.M.Temelkova,K. Adamova</AUTHORS><afflication>University Clinic of Endocrinology, Diabetes and Metabolic Disorders, Medical Faculty, Skopje, Republic of Macedonia,University Clinic of Endocrinology, Diabetes and Metabolic Disorders, Medical Faculty, Skopje, Republic of Macedonia,University Clinic of Endocrinology, Diabetes and Metabolic Disorders, Medical Faculty, Skopje, Republic of Macedonia,University Clinic of Endocrinology, Diabetes and Metabolic Disorders, Medical Faculty, Skopje, Republic of Macedonia,University Clinic of Endocrinology, Diabetes and Metabolic Disorders, Medical Faculty, Skopje, Republic of Macedonia</afflication></Article></Articles>